SCHEMBL353582

SCHEMBL353582

NC(=O)c1cccc2cc(-c3ccc4c(C(=O)N(c5ccc(Oc6ccccc6)cc5)c5ccc(Oc6ccccc6)cc5)cccc4c3)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
CHEK2 O96017 2/20 0.46
SIRT2 Q8IXJ6 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
CTNNB1 P35222 1/20 0.42
BCL2 P10415 1/20 0.41
MCL1 Q07820 1/20 0.41
BAD Q92934 1/20 0.41
KDR P35968 5/20 0.41
AURKA O14965 4/20 0.41
MET P08581 4/20 0.41
TEK Q02763 4/20 0.41
AURKB Q96GD4 4/20 0.41
SCN9A Q15858 1/20 0.41
ABL1 P00519 1/20 0.41
LCK P06239 1/20 0.41
LYN P07948 1/20 0.41
PARP10 Q53GL7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL353489 0.89 ALDH1A1 (0.53) KDM4EALDH1A1GAASIRT2SIRT1
SCHEMBL634882 0.78 KDM4E (0.65) KDM4EALDH1A1GAAKDRAURKA
SCHEMBL352878 0.74 PARP1 (0.51) KDM4EALDH1A1GAAKDRAURKA
SCHEMBL634716 0.74 KDM4E (0.53) KDM4EALDH1A1GAAKDRAURKA
SCHEMBL17292708 0.74 ATM (0.47) KDM4EALDH1A1GAASIRT2SIRT1
SCHEMBL353378 0.71 F10 (0.48) KDM4EALDH1A1GAAPARP1
SCHEMBL9548533 0.70 NR4A1 (0.60) ALDH1A1
SCHEMBL353581 0.70 CHEK2 (0.48) KDM4EALDH1A1GAACHEK2SIRT2
SCHEMBL10526332 0.70 PNLIP (0.54) KDM4EALDH1A1PARP10
SCHEMBL355595 0.69 TRPM8 (0.46) KDM4EALDH1A1GAASIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2418942-A1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS Sanford-Burnham Medical Research Institute (US) 2012-02-22 EP disclosed
US-20120015992-A1 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2012-01-19 US disclosed
US-8039668-B2 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015992-A1 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins HAX1, PRDX1, APOL1 KDM4E 4564/4885ALDH1A1 3983/4885GAA 4031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.